Home » Topics » BioWorld Science

BioWorld Science
RSS

GPR171 agonism ameliorates chronic neuropathic and inflammatory pain

April 8, 2022

New Fgf1a murine models of heart failure and metabolic syndrome developed

April 8, 2022

Soltego discloses new SIK inhibitors

April 8, 2022

Medshine Discovery patents AKR1C3 inhibitors

April 8, 2022

Cadila Healthcare discloses new ACP1 inhibitors

April 8, 2022

Seoul Techno Holdings identifies new compounds for cancer

April 8, 2022

Elastrin Therapeutics closes funding round to advance development of lead candidate

April 8, 2022

1st Bio Therapeutics presents new protein kinase inhibitors

April 8, 2022

Novel HlyU inhibitor VM-17 attenuates the virulence of V. vulnificus

April 8, 2022

Researchers in China find evidence in mice that bacteria in tumors help cancer cells metastasize

April 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.